![SIGA Technologies Inc](/common/images/company/N_SIGA.png)
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections i... SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections including smallpox. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.05 | -0.823723228995 | 6.07 | 6.25 | 5.92 | 527701 | 6.087484 | CS |
4 | -0.27 | -4.29252782194 | 6.29 | 6.61 | 5.64 | 363001 | 6.08600067 | CS |
12 | -1.38 | -18.6486486486 | 7.4 | 7.555 | 5.615 | 429235 | 6.29379853 | CS |
26 | -4.51 | -42.8300094967 | 10.53 | 10.77 | 5.615 | 613964 | 7.52012768 | CS |
52 | 0.94 | 18.5039370079 | 5.08 | 12.83 | 4.75 | 850780 | 8.3787671 | CS |
156 | -0.15 | -2.43111831442 | 6.17 | 26.99 | 4.215 | 2231300 | 12.68236529 | CS |
260 | 1.17 | 24.1237113402 | 4.85 | 26.99 | 3.96 | 1436652 | 12.22060577 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約